AI Article Synopsis
- The prevalence of opiate use is rising, affecting about 0.6% of the global population, leading to many infants being born with prenatal opioid exposure.
- Animal and human studies show that this exposure negatively impacts brain development and anatomy, but the effects of postnatal exposure on hospitalized infants are less understood.
- The review discusses the effects of both prenatal and postnatal opioid exposure on neurodevelopment and suggests resources and strategies to address and possibly reduce developmental setbacks in affected infants.
Article Abstract
The overall prevalence of opiate use has been increasing, currently affecting approximately 0.6% of the global population and resulting in a significant proportion of infants being born with prenatal opioid exposure. Animal and human models of prenatal opioid exposure demonstrate detrimental effects on brain anatomy as well as neurodevelopment. Less is known about the neurologic sequelae of postnatal opioid exposure in hospitalized infants. In this review, we summarize our current understanding of the impact of prenatal and postnatal opioid exposure on the brain and on neurodevelopment outcomes. We also identify resources and management strategies that may help mitigate neurodevelopmental delays and deficits associated with opioid exposure in this vulnerable population.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1542/neo.25-6-e325 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!